Rommelag will showcase its blow-fill-seal technology that collectively offers container production, aseptic filling, and container closure.
Rommelag will be showcasing its blow-fill-seal (BFS) technology at Achema 2018. According to Rommelag, the technology offers three advantages-container production, aseptic filling, and container closure-in one operation under closed conditions.
The BFS aseptic filling systems is a safer, more cost-efficient solution for packaging liquid and semi-solid pharmaceutical products than a bottlepack aseptic system, the company said. The company has supplemented its bottlepack range with various inspection systems that ensure maximum safety and cost-effectiveness throughout the packaging process.
For quality assurance in pharmaceutical production, Rommelag will also highlight its solutions for different needs, including equipment requirements, automatic visual inspection, tightness checks, and fully automated monitoring of critical product features within in-process control.
On the pharma services side, Rommelag will discuss the tailored system configurations it offers, the in-house support it provides for the planning phase of pharmaceutical production, and the after-sales service it provides from installation of the system by its own technicians to maintenance, repair, and complex modifications and retrofits.
Achema 2018 runs from June 11–15 in Frankfurt, Germany.
Source: Rommelag, Hall 3.0, Booth D49
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.